Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol (v2.15.0) and includes the addition of specific cancer types and identifiers related to the study, while significant details about the study's design and criteria have been removed.SummaryDifference38%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.